enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
Go back to enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial| (NASDAQ: NVNO) | Delayed: 10.60 -0.03 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.63 | 52 Week High | $ | |||
| Open | $10.60 | 52 Week Low | $ | |||
| Day High | $10.60 | P/E | N/A | |||
| Day Low | $10.60 | EPS | $ | |||
| Volume | 2,338 | |||||

